1. 1 Verdiman JW, Melo JV, Baccarani M, et al. Chapter 2. Myeloproliferative neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al. (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edition, Lyon, IARC. 2008; pp. 31-65.
2. 2 Arber DA, Orazi A, Hasserjian R et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127: 2391-2405.
3. 3 Verdiman JW, Melo JV, Baccarani M, et al. Chapter 2. Myeloproliferative neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al. (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th edition, Lyon, IARC. 2017; pp. 29-60.
4. 4 Gömöri G. Silver impregnation of reticulum in paraffin sections. Am J Pathol. 1937; 13: 993-1002, 5.
5. 5 Gianelli U, Vener C, Bossi A et al. The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis. Mod Pathol. 2012; 25: 1193-1202.